Effect of hospital-community-home collaborative health management on symptoms, cognition, anxiety, and depression in high-risk individuals for stroke

Table 1 General data of the two groups at high risk of stroke, n (%)

Patient data	Control group (n = 52)	Observation group (n = 58)	χ2/t	P value
Age, years	59.27 ± 9.45	61.29 ± 10.73	1.043	0.300
Sex			0.736	0.391
Male	29 (55.77)	37 (63.79)
Female	23 (44.23)	21 (36.21)
Weight, kg	58.69 ± 8.69	59.67 ± 9.18	0.573	0.568
Educational level			0.666	0.717
Junior high school and below	14 (26.92)	12 (20.69)
Senior high school	22 (42.31)	28 (48.28)
University or above	16 (30.77)	18 (31.03)
Hypertension			2.628	0.105
With	30 (57.69)	42 (72.41)
Without	22 (42.31)	16 (27.59)
Diabetes			1.014	0.314
With	15 (28.85)	22 (37.93)
Without	37 (71.15)	36 (62.07)
Hyperlipidemia			0.822	0.365
With	26 (50.00)	24 (41.38)
Without	26 (50.00)	34 (58.62)

Table 2 Stroke awareness scores of two high-risk groups for stroke, mean ± SE

Dimensions	Control group (n = 52)	Observation group (n = 58)	t	P value
Risk factor cognition	13.96 ± 3.51	19.9 ± 3.38	9.036	< 0.001
Prevention knowledge cognition	15.75 ± 2.93	22.36 ± 3.39	10.880	< 0.001
Early symptom cognition	16.94 ± 3.84	23.14 ± 3.25	9.169	< 0.001
Emergency treatment cognition	14.90 ± 2.58	18.19 ± 3.31	5.766	< 0.001

Table 3 Health behavior levels of two high-risk groups for stroke, mean ± SE

Dimensions	Control group (n = 52)	Observation group (n = 58)	t	P value
Health responsibility	18.67 ± 5.68	21.60 ± 4.84	2.920	0.004
Exercise	18.60 ± 2.97	24.38 ± 3.78	8.846	< 0.001
Nutrition	18.12 ± 5.38	24.71 ± 6.17	5.939	< 0.001
Stress management	19.79 ± 4.71	26.33 ± 4.72	7.263	< 0.001
Interpersonal relationships	19.04 ± 5.30	21.69 ± 4.62	2.802	0.006
Self-actualization	14.73 ± 3.80	18.81 ± 4.90	4.839	< 0.001

Table 4 Standardized medication of two high-risk groups for stroke, n (%)

Standardized medication	Control group (n = 52)	Observation group (n = 58)	χ2	P value
Antiplatelet drugs	42 (80.77)	55 (94.83)	5.200	0.023
Statins	40 (76.92)	54 (93.10)	5.775	0.016
Antihypertensive drugs	41 (78.85)	57 (98.28)	10.650	0.001
Hypoglycemic agents	42 (80.77)	56 (96.55)	7.027	0.008

Table 5 Blood pressure and serum biochemical indices of two high-risk groups for stroke

Indicators	Control group (n = 52)	Observation group (n = 58)	t	P value
SBP
Before intervention	130.83 ± 10.53	129.57 ± 12.31	0.574	0.568
After intervention	125.87 ± 9.70	122.41 ± 6.26	2.245	0.027
DBP
Before intervention	84.87 ± 8.13	86.52 ± 9.92	0.947	0.346
After intervention	79.54 ± 7.66	76.03 ± 6.22	2.649	0.009
TG
Before intervention	2.28 ± 0.50	2.23 ± 0.52	0.513	0.609
After intervention	1.95 ± 0.46	1.45 ± 0.35	6.454	< 0.001
TC
Before intervention	4.58 ± 1.37	4.72 ± 1.39	0.531	0.597
After intervention	4.38 ± 1.27	3.80 ± 1.40	2.266	0.025

SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TG: Triglyceride; TC: Total cholesterol.

Table 6 Psychological and emotional changes in two high-risk groups for stroke

Indicators	Control group (n = 52)	Observation group (n = 58)	t	P value
SAS score
Before intervention	52.58 ± 16.35	53.74 ± 12.70	0.418	0.677
After intervention	45.58 ± 9.69	39.76 ± 7.60	3.523	< 0.001
SDS score
Before intervention	54.77 ± 13.81	50.74 ± 10.89	1.708	0.091
After intervention	46.96 ± 11.61	42.47 ± 8.82	2.298	0.024

SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.